Beyond HNSC, ERP44 dysregulation has been documented in diverse malignancies including gastric cancer, lung cancer, and gliomas, where it influences proliferation, apoptosis resistance, and endoplasmic reticulum stress [23–25]. Here, ERP44 is linked to lung carcinoma.